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Abstract
Background: The proinflammatory cytokine, TNFa, is a crucial mediator of the pathogenesis of several diseases, more so in
cases involving the liver wherein it is critical in maintaining liver homeostasis since it is a major determiner of hepatocyte life
and death. Gene expression profiling serves as an appropriate strategy to unravel the underlying signatures to envisage
such varied responses and considering this, gene transcription profiling was examined in control and TNFa treated HepG2
cells.
Methods and Findings: Microarray experiments between control and TNFa treated HepG2 cells indicated that TNFa could
significantly alter the expression profiling of 140 genes; among those up-regulated, several GO (Gene Ontology) terms
related to lipid and fat metabolism were significantly (p,0.01) overrepresented indicating a global preference of fat
metabolism within the hepatocyte and those within the down-regulated dataset included genes involved in several aspects
of the immune response like immunoglobulin receptor activity and IgE binding thereby indicating a compromise in the
immune defense mechanism(s). Conserved transcription factor binding sites were identified in identically clustered genes
within a common GO term and SREBP-1 and FOXJ2 depicted increased occupation of their respective binding elements in
the presence of TNFa. The interacting network of ‘‘lipid metabolism, small molecule biochemistry’’ was derived to be
significantly overrepresented that correlated well with the top canonical pathway of ‘‘biosynthesis of steroids’’.
Conclusions: TNFa alters the transcriptome profiling within HepG2 cells with an interesting catalog of genes being affected
and those involved in lipid and steroid metabolism to be the most favored. This study represents a composite analysis of the
effects of TNFa in HepG2 cells that encompasses the altered transcriptome profiling, the functional analysis of the up- and
down- regulated genes and the identification of conserved transcription factor binding sites. These could possibly
determine TNFa mediated alterations mainly the phenotypes of hepatic steatosis and fatty liver associated with several
hepatic pathological states.
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Introduction
The multifunctional proinflamatory cytokine, TNFa (Tumor
Necrosis Factor a) has effects on lipid metabolism, coagulation,
insulin resistance, and endothelial function and therefore is
important in cellular pathophysiology. It induces the activation
of predominantly two signaling pathways within the cell – one
involving the transcription factor NF-kB (Nuclear Factor-kB) that
lies inactive in the cytosol and is activated on TNFa binding to its
receptor on the membrane and the other involves the MAPK
(Mitogen Activated Protein Kinase) pathway [1–3]. Both these
pathways underlie the basic mechanism(s) of TNFa action in
several pathological conditions. TNFa is widely implicated in
various diseases. Although primarily known to be associated with
inflammation, TNFa now occupies a central place in the crosstalk
of many pathological states. It plays a major role in muscular
abnormalities resulting in muscle wasting [4], idiopathic pulmo-
nary fibrosis [5], rheumatoid arthritis [6], Crohn’s disease [7] and
psoriasis [8]. Several other diseases like cerebral malaria [9],
asthma [10,11] and cystic fibrosis [12] also have a strong
correlation to TNFa levels. Chronic inflammation is also
frequently associated with the metabolic syndrome and TNFa is
one of the significant mediators between the two states [13]. The
metabolic syndrome is a cluster of metabolic abnormalities leading
to increased risk for cardiovascular diseases and diabetes type 2
and herein visceral obesity and the resulting insulin resistance are
the major determinants in the development of this syndrome [14].
The liver is central to metabolic control and actively participates
in storing and releasing glucose, nitrogen metabolites and lipids as
and when required. It is also majorly involved in detoxification
mechanisms and is, therefore, no doubt significant for proper
functioning of the body and any liver injury is extremely
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and death are the major hallmarks in all liver diseases [15] and it is
during these conditions that the liver is exposed to increased levels
of TNFa apart from other inflammatory cytokines. Serum and
hepatic TNFa levels are increased in patients with HBV and HCV
infection [16–18] and also in subjects with detectable liver failure
and other liver injuries [19,20]. In all these cases, TNFa along
with other cytokines participate in initiating a wound healing
response [15] or mediate hepatocyte damage [21,22]. Paradoxi-
cally, although harmful to the injured hepatocyte, TNFa induces
healthy hepatocytes to proliferate rather than die [23]. This
especially occurs as a conditioned response against any hepatec-
tomy or liver regeneration. Thus to maintain normal liver integrity
and homeostasis by either hepatocyte death as observed during
liver injury or by inducing hepatocyte proliferation during liver
regeneration depends on whether TNFa-induced apoptosis or cell
survival pathways, respectively are predominant. All these imply
that TNFa is very critical in liver function and its increased levels
exert several pleiotropic effects thereby emphasizing the need for a
detailed understanding of hepatic TNFa action [15].
In view of these varied effects of TNFa, we sought to study the
TNFa-induced alteration in gene expression patterns within the
hepatocyte, the common pathways they fall in and to find a
correlation among co-regulated genes. Our results demonstrate a
significant number of hepatic genes to be statistically altered by
TNFa and the most significant pathway and network to be
targeted predominantly involved those of lipid metabolism,
cholesterol and steroid biosynthesis. Interestingly, conserved
transcription factors’ binding sites were found in these sets of
genes that could determine the correlation between the altered
gene set and the hepatic processes favored by TNFa. Although
earlier studies [24,25] have shown some specific effects of TNFa
on HepG2 cells, our results demonstrate a wholesome analysis of
TNFa effect on HepG2 cells that correlates the altered
transcriptome profile with identification of conserved transcription
factor binding sites that could determine several hepatic
pathological states.
Methods
Cell Culture and Treatment
Experiments were done in HepG2 (human hepatocellular
carcinoma) cells obtained from the National Centre for Cell
Science, Pune, India. HepG2 cells retain several functions of the
normal human liver including synthesis of albumin, lipoprotein
and several other liver specific functions. Among these functions
notable are those related to cholesterol and triglyceride metabo-
lism. In several hepatic physiological states, inflammation within
the liver is a significant accompanying phenomenon along with the
accumulation of lipid vesicles. Dysregulation of liver metabolism
and hepatic inflammation run in parallel in several liver diseases
and thereby inflammation within the liver predisposes it to the
onset of a number of hepatic pathologies. HepG2 cells are
recognized as an in vitro human model system and are identified as
a possible bioartificial liver [26] thereby corroborating their use as
a resource to study several hepatic functions and for metabolic
studies [27]. They were maintained in DMEM supplemented with
10% fetal calf serum with 1% antibiotic-antimycotic (100 units/ml
penicillin, 0.1 mg/ml streptomycin and 0.25 mg/ml amphoterecin
B) at 37uC in a humified atmosphere of 5% CO2. On attaining
confluence, cells were serum starved overnight and incubated in
the absence (control) and presence of TNFa (Sigma Chemical Co.,
St. Louis, USA; 0.5 nM, 12 h). The dose and time were chosen
becausein HepG2 cells, we had observed optimum inhibition of
insulin-stimulated Akt activation that plateaued thereafter at
further dose and time points. The total levels of the Akt protein,
however, remained constant (Figure S1).
RNA Isolation
On termination of incubation, total RNA was isolated from cells
using Trizol (Invitrogen) according to the manufacturer’s instruc-
tions and subjected to a cleanup using RNeasy protect Mini Kit
(Qiagen, Germany). RNA was quantified in a NANODROP
spectrophotometer (ND 1000) and the ratios of OD260/280 nm
were between 1.8–2.0. The integrity of RNA samples was
determined in the Bioanalyser 2100 System (Agilent Technologies,
Palo Alto, CA) and all samples had RIN (RNA integrity number)
values between 8.0–8.5.
Microarray and Data Analysis
Microarray experiments were performed in triplicate (three
control and three TNFa- treated) at The Centre for Genomic
Applications (TCGA), New Delhi, India according to the
manufacturer’s instructions (Affymetrix, Santa Clara, USA).
Briefly, RNA (control and TNFa treated) was reverse transcribed
to cDNA that was subjected to in vitro transcription to produce
biotinylated cRNA that was hybridized to the human array chip
(Human Genome U133 Plus 2.0, Affymetrix). Images were
scanned using the GeneChip 3000 7G scanner (Affymetrix).
Signal intensities and absolute call dataset were generated with
Affymetrix Gene Chip Operating Software (GCOS) using the
MAS5.0 algorithm. This resulted in normalized values of each
chip to a target intensity of 500 as detailed in the Affymetrix
statistical algorithm. The efficiency of the labeling reaction and
hybridization performance was assessed by the optimal 39/59
hybridization ratios for the housekeeping genes, poly-A-spike in
controls and the prokaryotic controls. Detection calls identified
transcripts to be either reliably detected (Present) or below the
background levels (Absent) if the detection p-value was above or
below 0.05 respectively. Genes with present calls in at least 2 out of
the three replicates were included in the analysis that was done
with Microsoft Excel 2007 using the steps as described in http://
jura.wi.mit.edu/bio/education/bioinfo2007/arrays/. The data
were normalized such that the average expression of the present
genes in all the samples was identical, log transformed and
statistical analysis was done with student’s t-test. Genes were
filtered on the basis of call, fold change and p value. All genes
with a signal log ratio .60.5 (1.41 fold) and p value ,0.05 were
chosen to be statistically altered by TNFa. The 1.41-fold criterion
as a minimum cutoff for change is chosen based on the literature
reported earlier in HepG2 cells [28]. The study was in accordance
to the MIAMI guidelines and the microarray data have been
submitted to the Gene Expression Omnibus (GEO) database [29].
Accession number for the data is GSE12161.
Real Time PCR
Real Time quantitative PCR was done for validation of gene
expression microarray data. Total RNA (Control and TNFa-
treated) was isolated as described above and 2 mg RNA from each
set was reverse transcribed using MMuLV reverse transcriptase
and random hexamers. 2 ml of this was amplified in a final volume
of 25 ml using the SYBR Green Real Time PCR Master Mix
(Applied Biosystems) and gene specific primers. After an initial
activation at 50uC for 2 min and a preincubation step at 95uC for
10 min, reaction mixtures were subjected to 40 cycles of
denaturation at 95uC for 15 sec, annealing at 56uC for 30 sec
and extension at 72uC for 35 sec (ABI 7500). This was followed by
a dissociation curve analysis at 95uC for 15 sec, 60uC for 20 sec
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2001 [30] and 18S rRNA was taken as the internal control. No
RT control (without the reverse transcriptase) and a no template
control (without the RNA template) were taken as the negative
controls for the experiments. All experiments were done in
triplicate.
Gene Ontology (GO) Classification and Cluster Analysis
Genes that were found to be significantly altered by TNFa were
classified into categories of biological processes and molecular
functions using Gene Ontology Tree Machine (GOTM, [31]) and
DAVID [32]. Genes over-represented in our dataset in the context
of the reference set (Human Genome U133 Plus 2.0 chip,
Affymetrix) were determined with the GO Tool Box [33] using
Bonferroni correction. Genes were then clustered on the basis of
their normalized expression intensities using the Avadis software
(version 3.1, Stratagene).
Promoter and Pathway Analysis
To identify the likely identical regulatory controls among the
altered genes, genes common to a single cluster and Gene
Ontology term were taken for promoter analysis. 5.0 kb upstream
regions from the transcription start sites of such genes were
retrieved using Ensembl [34] and the transcription factor(s)
binding within this region was determined using Over-represented
Transcription Factor Binding Site Prediction (OTFBS, Release
6.0.) tool [35] that detects over-represented motifs of known
transcription factors within groups of related sequences. This was
done considering the fact that genes with similar function as well as
expression profiles are more likely to be under the same regulatory
control than genes within either of the categories [36]. Also to
categorically determine which specific pathways the altered genes
map to and to determine the interacting network among them, if
any, the dataset containing the gene identifiers alongwith the
corresponding fold changes were uploaded into the Ingenuity
Pathways Analysis program. Each identifier was mapped to its
corresponding gene object in the Ingenuity knowledge base. A
1.41 fold change (log ratio 60.5) was set to identify genes whose
expression was significantly differentially regulated. These genes,
called focus genes, were overlaid onto a global molecular network
developed from information contained in the Ingenuity knowledge
base. Networks of these focus genes were then algorithmically
generated based on their connectivity. A graphical representation
of the molecular relationships between these genes is shown where
genes or gene products are represented as nodes, and the
biological relationship between two nodes is represented as an
edge (line). All edges are supported by at least 1 reference from the
literature, from a textbook, or from canonical information stored
in the Ingenuity knowledge base. Human, mouse, and rat
orthologs of a gene are stored as separate objects in the Ingenuity
knowledge base, but are represented as a single node in the
network. The intensity of the node color indicates the degree of
up- (red) or down- (green) regulation. Canonical Pathways
Analysis identified the pathways from the Ingenuity Pathways
Analysis library of canonical pathways that were most significant
to the dataset. Genes from the dataset with a 1.41 fold change (log2
ratio 60.5) were associated with a canonical pathway in the
Ingenuity knowledge base and considered for the analysis. The
significance of the association between the dataset and the
canonical pathway was measured in 2 ways: 1) A ratio of the
number of genes from the dataset that met the expression value
cutoff that map to the pathway divided by the total number of
molecules that exist in the canonical pathway is displayed. 2)
Fischer’s exact test was used to calculate a p-value determining the
probability that the association between the genes in the dataset
and the canonical pathway is explained by chance alone.
Electrophoretic Mobility Shift Assay (EMSA)
The electrophoretic mobility shift assay analysis was done
essentially as described by Shiraga et al. [37]. Briefly nuclear
extracts were prepared from control and TNFa-treated (0.5 nM,
12 h) HepG2 cells by lysing the cell pellets in a buffer containing
10 mM HEPES (pH 7.4), 1.5 mM MgCl2, 10 mM KCl, 1 mM
DTT, 0.1 mM EDTA, 0.1 mM EGTA, 0.25% Nonidet P-40 and
protease inhibitor cocktail (final concentration 1X, Sigma, St.
Louis, MO, USA) and incubating in ice for 15 min. These were
then centrifuged at 10,000 g for 15 min at 4uC. The pellets
obtained were resuspended in nuclear lysis buffer (20 mM HEPES
(pH 7.4), 1.5 mM MgCl2, 40 mM NaCl, 1 mM DTT, 0.1 mM
EDTA, 0.1 mM EGTA, 25% glycerol and protease inhibitor
cocktail (final concentration 1X, Sigma, St. Louis, MO, USA)) and
incubated on ice for 30 min with intermittent shaking. The
supernatant obtained after centrifugation of the nuclear lysates at
17,000 g for 15 min at 4uC were taken as the nuclear fraction and
used for the binding studies.
Double stranded DNA was generated by mixing equimolar
amounts of the complementary oligonucleotides in annealing
buffer (Ambion, CA, USA). Mutated sequences of the transcrip-
tion factors were also used to check the specificity of the binding of
the transcription factors. These annealed double stranded DNA
were labeled with [c
32-P]-ATP (BRIT, Hyderabad, India) in the
presence of T4-polynucleotidekinase (New England Biolabs, MA,
USA) according manufacturer’s instructions. Nuclear extracts
(15 mg) from the control and TNFa-treated cells were incubated
for 30 min at room temperature in the presence of reaction buffer
containing 8 mM Tris-KCl (pH 8.0), 2 mM EDTA, 1 mM DTT,
12% glycerol, 1 mg BSA and 1 mg of poly(dI-dC). Either the wild
type or mutated labeled double stranded oligonucleotide
(40,000 cpm) was then added to the reaction mixture and
incubated for 45 min at room temperature. On termination of
incubation, samples were loaded onto a non-reducing 5%
polyacrylamide gel and electrophoresed in 0.5XTBE. Gels were
then dried and subjected to phosphorimager analyses (FLA 2000,
Fujifilm, Japan). The densitometric analyses were done using the
Alpha DigiDoc 1201 software (Alpha Innotech Corporation, CA,
USA). The same size rectangle box was drawn surrounding each
band and the intensity of each was analyzed by the program after
subtraction of the background intensity.
Cholesterol Synthesis
On attaining confluence, HepG2 cells were incubated in the
absence or presence of TNFa (0.5 nM, 12 h). Additionally to
determine which specific step of the steroid biosynthetic pathway is
the most significant contributor for TNFa action herein, gene
specific siRNAs were used to categorically knock down specific
genes. HepG2 cells were transfected with 50 nM of either control
or specific siRNAs (Santa Cruz, CA, USA) according to the
manufacturer’s instructions. After allowing the cells to grow in
fresh DMEM for 48 h, they were incubated with TNFa (0.5 nM,
12 h) and on termination of incubation, cells were lysed and lipids
were extracted by addition of 1.0 ml of chloroform: methanol
(2:1). These lipid extracts were vacuum dried and the residues
were dissolved in 2-propanol containing 10% Triton-X-100.
Cholesterol was estimated in an analyser (COBAS INTEGRA
400 plus, Roche, Germany) according to the manufacturer’s
instructions. Results are expressed after normalization to the total
protein content (DC Protein Assay Kit, BIORAD, CA).
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Microarray data from three replicate experiments generated by
GCOS were exported to Microsoft Excel 2007 for further
analysis and is described above. A value of p,0.05 was taken to
be statistically significant. Only those genes with present calls in
at least 2 out of 3 replicates were analyzed and a cutoff value for
differential gene expression was defined as transcripts that
showed a.1.41 fold change and a t-test p value of ,0.05. RT-
PCR was done in triplicates and data presented are means6
S.E.M of three independent experiments. Statistical significance
between the control and treated groups was determined using
Student’s t-test where p#0.05 was considered as statistically
significant.
Results
TNFa Induced Alteration in Gene Expression in HepG2
Cells
To identify genes altered by TNFa in HepG2 cells, mRNA
expression in these cells incubated in the absence and presence of
TNFa (0.5 nM, 12 h) was analysed using whole genome
oligonucleotide expression arrays (Human Genome U133 Plus
2.0, Affymetrix). TNFa treatment significantly (p,0.05) altered
the expression of 140 genes in HepG2 cells. Figure 1 shows the
volcano plot of the microarray hybridization with the significantly
up-regulated genes being represented with red colored boxes and
those down regulated with green ones. Those that were not
significantly altered are depicted in black dots. These altered genes
were classified into functional categories of biological processes
using Gene Ontology Tree Machine (GOTM) and DAVID. The
GO database has a hierarchical nature such that genes annotated
with a specific node (GO term) are also annotated with every
ancestor of that node with the result that the genes map onto more
than one GO term. A functional GO class thereby included genes
assigned in the listed GO term by the GO consortium or a more
specific break-up of the listed term that reflects in the gene being
classified in more than one GO term. From our dataset, genes that
clearly mapped onto a single GO term were assigned as such and
for others that mapped onto more than one GO term, we put
genes in the term where there was experimental validation
available and when not, we put them in a particular GO class
considering their functional closeness to other members of that
class. Table S1 gives the Gene Ontology terms, the fold change
and the p value of the significantly altered genes. Of these, 67
genes were up-regulated and 73 were down-regulated with a
minimal fold change of 61.41 (log2 ratio $60.5). Genes involved
in cell adhesion like Laminin (gamma 1, 21.4 fold), Tao kinase2
(21.6 fold) and Fibroblast Growth Factor Receptor-Like 1 (21.5
fold) were significantly down regulated by TNFa. Almost all the
genes involved in response to stimulus (HSPA1B, ORM2, MST1,
H3/O and C4B) and regulation of biological processes (PUM1,
CEBPa and BRPF1) were down regulated. While some genes of
signal transduction like FCER1G, RASSF7, NR1H4 and RGL3
were significantly (p,0.05) down regulated, others of the same
category like MKNK2, RYK, NFKB2, IL22RA1, THRAP6 and
KISS1R were upregulated. Further upregulated genes were
involved in transport such as GOSR2 (+1.4 fold), HCN3 (+1.7
fold), SYTL1 (+1.4 fold), SLC43A2 (+1.9 fold) and SLC27A5 (+2
Figure 1. A volcano plot of genes altered by TNFa in HepG2 cells. Log2 fold changes and their corresponding p-values of all genes in the
microarray were taken for construction of the volcano plot. Genes up-regulated with more than 1.5 fold change with a p-value ,0.05 are depicted in
red boxes and those down regulated with identical fold change and p-value are in green boxes. All other genes in the array that were not found to be
significantly altered are in black dots.
doi:10.1371/journal.pone.0009063.g001
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PAFAH2 (+2 fold), FADS (+1.7 fold), SQLE (+2.5 fold), HSD17B7
(+1.7 fold) and IDH2 (+1.5 fold). While genes involved in
carbohydrate metabolism, for e.g. AKR1B1, GNPDA2, and
PDK3 were significantly downregulated, some genes of nucleic
acid and amino acid metabolism like PAH, NDUFS1, DHFR
and TNRC9 were upregulated. Others like STOM, UBE2J1,
SCRN3 (protein metabolism), SIRT6, ELF5, DNMT3B (nucleic
acid metabolism), AP3B1, SLC6A12, STXBP5, AP1S2, AQP3
(transport) and TIMP1 were significantly downregulated. Inter-
estingly genes involved in cellular homeostasis i.e. calreticulin
(21.6 fold) and protein disulfide isomerase (21.9 fold) were also
downregulated.
Real Time PCR Validation of Microarray Data
Quantitative real time PCR was done to validate a group of
selected up- and down-regulated genes. The primer sets used are
shown in Table 1. The experiment was done for FADS1, SQLE,
PDIA4, HSP90B, CEBPa, CALR, FDPS, MST1, PDK3, AQP3
and NFKB2. As in the results of the microarray analysis, all these
genes depicted an identical pattern of alteration as compared to
the control. In TNFa treated cells, PDIA4, HSP90B1, CEBPa,
CALR, MST1, PDK3 and AQP3 showed an inhibition of the
transcript levels while FADS1, SQLE, FDPS and NFKB2 showed
increased levels (Figure 2).
Functional Classification of Genes Altered by TNFa in
HepG2 Cells
All the 67 up-regulated and 73 down-regulated genes were
separately grouped into molecular functions using the GO Tool
Box. At Level 3, molecular functions that emerged specifically as
being altered among the up-regulated genes were those of lipid
binding and ligase activity while those of transcription repressor
and enzyme inhibitor activities were specific to the down-regulated
genes. Figures 3A and B depict respectively the fraction of TNFa
induced up- and down- regulated genes in HepG2 cells among the
various molecular functions as identified by the GO Tool Box.
Significantly (p,0.01) over represented Gene Ontology terms
(molecular function) in down- and up- regulated genes are shown
in Tables 2A and B respectively. The tables give the number of
genes with that gene ontology term on the Human Genome U133
Plus 2.0 array, the number of genes in the same gene ontology
term in our altered dataset and the p value of the occurrence of
that number of genes in the dataset. For genes up-regulated by
TNFa, several gene ontology terms related to lipid and fat
metabolism like keto-steroid reductase activity, cholate-CoA ligase
activity, squalene monooxygenase activity, oxidoreductase activity
were significantly (p,0.01) over represented indicating an overall
favor of genes involved in fat metabolism within the hepatocyte by
TNFa. GO terms involved with immune responses like IgE
receptor activity, immunoglobulin receptor activity and IgE
binding were also highly over represented in the down-regulated
set indicating a compromise in immune defense mechanism(s). An
identical analysis using the GO class: biological processes
identified several genes belonging to the steroid and lipid
metabolic processes to be significantly (p,0.01) over-represented
among the up-regulated set and those very specifically involved in
diverse aspects of the overall immune response to be significantly
(p,0.01) over represented in the down-regulated set of genes
(Table S2).
Clustering and Promoter Analyses
TNFa induced up- and down- regulated genes were clustered
hierarchically on the basis of their normalized expression
intensities (Figure S2) and genes with the same GO functional
term and within the same cluster were selected for further
promoter analysis. Example results of genes from three GO terms
i.e. ‘‘Metabolism’’, ‘‘Signal Transduction’’ and ‘‘Regulation of
Biological Process’’ that clustered together were taken for
promoter analysis. A 5kb upstream sequence from the transcrip-
tion start site of each of these genes was retrieved and the binding
sites of transcription factors within this region were determined as
described above. Table 3 is a list of the transcription factor binding
sites in a set of clustered genes within the indicated GO term.
Significant transcription factors consistently occurring in the
promoters of genes altered by TNFa and clustering together with
common GO terms included SREBP-1, CEBPa, MEF2 and
AREB6. All these are in several ways implicated in cellular
metabolic processes and immune response, two phenomena that
are modulated by TNFa. Surprisingly, binding sites of several
members of the forkhead family of transcription factors, that are
however not well characterised were also significantly found to be
overrepresented in our dataset. These included FOXJ2, FOXD3
and the fork head homolog-3 (HFH-3). The biological relevance of
these relatively less characterized transcription factors remain to
be investigated.
Table 1. Primers used for microarray gene expression validation.
Gene Symbol Forward primer 59-39 Reverse primer 59-39 AmpliconSize(bp)
HSP90B1 AATCTGGGACAAGCGAGTTTTT GCGGAATAGAAACCGACACCA 103
FDPS CCAAGAAAAGCAGGATTTCGTTC CCGGGCAATAGCATCTCCTA 100
PDIA4 TCCCATTCCTGTTGCCAAGAT GCCCTCGTAGTCTACAGCCT 121
SQLE CCACTGACTGTTGTTGCAGAT TGAGAACTGGACTCGGGTTAG 253
FADS1 TTGTACCTCCATTGGCTTCC CAGCCTATGCCCAAAGCTAC 122
CALR GTTTCGAGCCTTTCAGCAAC TCTGAGTCTCCGTGCATGTC 142
CEBPa ACGATCAGTCCATCCCAGAG TTCACATTGCACAAGGCACT 122
PDK3 TGGTTCCTACAATGGCACAA GGAAAGAGATGCGGTTGGTA 120
AQP3 GAGCATCCACTGACTGTCCA AAATCCTGAAGGGGCTGTCT 116
MST1 CACAGCCAATACCACCACTG GGTCTTTGCACGCGTATTTT 101
NFKB2 ACTACCTCCCACCTCGTCCT ACGCCTCTTGACCTCACT 124
doi:10.1371/journal.pone.0009063.t001
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To validate the transcription factors that were found to possess
binding sites in the promoters of genes that were altered by TNFa
as described above, electrophretic mobility shift assay was
performed for two of the candidate transcription factors namely,
SREBP-1 and FOXJ2. Wild type and mutated oligonucleotide
sequences that were used are given in Table 4. As compared to the
incubation in the presence of the free labeled probe alone, the
addition of the nuclear extract from the control cells caused
significant formation of the DNA-protein complex both with
SREBP-1 (Figure 4A, B) and FOXJ2 (Figure 4C, D) oligonucle-
otides. This complex formation was significantly enhanced in the
presence of nuclear extracts from TNFa-treated cells indicating
that TNFa increased the binding of these transcription factors to
their binding elements that corroborates with our predicted
findings detailed above. No detectable DNA-protein complexes
were identified with the mutated oligonucleotides of either
SREBP-1 or FOXJ2 that additionally suggests the specificity of
the DNA-protein complexes observed.
Network and Pathway Analyses
We then wanted to identify the interacting network among the
altered genes in the context of other large biological pathways.
We began by analyzing TNFa-induced altered genes using the
Ingenuity Pathway Analysis software that generates networks,
associated biological functions and canonical pathways by
overlaying them onto a global molecular network developed
from information contained in the Ingenuity knowledge base.
Five highly significant networks with scores above 20 were
obtained from the set of TNFa induced altered genes. These
scores, derived from p values, indicated the likelihood of the focus
genes belonging to a network versus those obtained by chance
alone thereby eliminating the probability of their occurrence in a
network to be due to noise. The network with the highest score
comprised that of hematological system development and
function, immune and lymphatic system development and
function and tissue morphology. Other subsequent networks
with decreasing scores included those of (i) immunological
disease, skeletal and muscular disorders and inflammatory disease
(ii) lipid metabolism, small molecule biochemistry, nervous system
development and function, (iii) cell signaling, post translational
modification, dermatological diseases and conditions and (iv)
cellular growth and proliferation, cancer and hematological
disease. This implies that the altered genes were distributed
among diverse networks that could be expected considering the
varied cellular actions of TNFa. Interestingly, while ‘‘biosynthesis
of steroids’’ was the top canonical pathway that was significantly
(with a p value of 1.27E-03) altered by TNFa in HepG2 cells,
‘‘lipid metabolism’’ was the most significant (1.70E-04-4.39E-02)
molecular and cellular function to be affected. So we further
analyzed the network 3 of the list of significantly affected
networks i.e of lipid metabolism, small molecule biochemistry,
nervous system development and function since it could also be
correlated well with the most significantly affected canonical
pathway and molecular and cellular function. Figure 5 shows the
associated network functions of this interaction. One of the key
central points in this network is that of insulin (INS1). Apart from
regulating FADS1, INS1 indirectly also regulates HRAS that
inturn regulates SQLE, these are the two significantly upregu-
lated genes in our dataset. Insulin was postulated some time ago
by Satoh et al., 1990 [38] to regulate SQLE and insulin
regulation of hepatic desaturases has also been described [39].
INS1 is directly regulated by HNF1A that in turn interacts with
AQP3 and PAFAH2 that were down and up regulated,
respectively, in our experiment. HRAS shows interactions with
SQLE, PCYT1A and 1B, genes that were differentially regulated
by TNFa. Another central point in this interaction network was
occupied by RHOA (ras homolog gene family, member A). Two
of the significantly altered genes from our list, HSPA1A and
RGNEF, were found to be binding strongly with RHOA.
Interestingly, RHOA is also regulated by HRAS on one end
and INS1 on the other, although indirectly. All these indicate a
cross talk among molecules that otherwise seem to be distantly
placed in biological pathways and therefore many positions of this
Figure 2. Validation of microarray gene expression data by Real Time PCR. HepG2 cells were treated in the absence and presence of TNFa
(0.5 nM, 12 h) and the isolated total RNA was subjected to Real time PCR with gene specific primers as listed in Table 2. Values of each gene were
normalized to those of 18S rRNA and are plotted with respect to the control that has arbitrarily been taken as 1. Each value is the mean 6 SEM of
three independent experiments. *p,0.01 as compared to control. **p,0.05 as compared to control.
doi:10.1371/journal.pone.0009063.g002
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explains to some extent the diverse effects of TNFa on cellular
physiology.
Figure 6 shows the ‘‘biosynthesis of steroids’’ pathway obtained
using the Ingenuity Pathway Analysis tool that was derived as the
most significant pathway being affected by our set of TNFa
induced altered genes. Most of the affected genes clustered at
significant points of the cholesterol biosynthetic pathway. These
include three isoforms of farnesyl diphosphate synthase (FDPS, EC
nos. 2.5.1.1; 2.5.1.10; 2.5.1.29), squalene expoxidase (SQLE, EC
no. 1.14.99.7) and emopamil binding protein (EBP, sterol
isomerase, EC. no. 5.3.3.5). All these were upregulated and have
been marked with red diamond boxes in the figure with the
intensity of the color being an indicator of the fold of up-
regulation. Two of these namely SQLE and FDPS were also
validated by Real-Time PCR (Figure 2). Phenotypically, as a
Figure 3. Classification of TNFa-regulated genes into functional groups. HepG2 genes that were altered by TNFa were classified on the
basis of molecular functions using the GO Tool Box. Fraction of genes and the corresponding GO terms from the up-regulated set are shown in A and
the same from the down regulated set are depicted in B.
doi:10.1371/journal.pone.0009063.g003
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PLoS ONE | www.plosone.org 7 February 2010 | Volume 5 | Issue 2 | e9063Table 2. Gene Ontology (Molecular Function) terms overrepresented (p,0.01) in the set of genes up- and down- regulated by
TNFa.
A. Overrepresentation of down-regulated genes
GO_ _ID TERM NB_ _IN_ _REF NB_ _IN_ _SET pVAL
GO:0003677 DNA binding 3525 14 0.000379
GO:0005515 protein binding 8667 23 0.001096
GO:0016429 tRNA (adenine-N1-)-methyltransferase activity 1 1 0.001522
GO:0019767 IgE receptor activity 1 1 0.001522
GO:0004361 glutaryl-CoA dehydrogenase activity 1 1 0.001522
GO:0008326 site-specific DNA-methyltransferase (cytosine-specific) activity 1 1 0.001522
GO:0016426 tRNA (adenine)-methyltransferase activity 1 1 0.001522
GO:0019763 immunoglobulin receptor activity 2 1 0.00304
GO:0004105 choline-phosphate cytidylyltransferase activity 2 1 0.00304
GO:0051082 unfolded protein binding 202 3 0.003357
GO:0004032 aldehyde reductase activity 3 1 0.004553
GO:0004740 (pyruvate dehydrogenase (lipoamide)) kinase activity 4 1 0.006061
GO:0030414 protease inhibitor activity 270 3 0.0073
GO:0008757 S-adenosylmethionine-dependent methyltransferase activity 87 2 0.007487
GO:0008168 methyltransferase activity 273 3 0.007515
GO:0019863 IgE binding 5 1 0.007565
GO:0016741 transferase activity, transferring one-carbon groups 277 3 0.007806
GO:0009008 DNA-methyltransferase activity 6 1 0.009065
GO:0005007 fibroblast growth factor receptor activity 6 1 0.009065
B. Overrepresentation of up-regulated genes
GO_ _ID TERM NB_ _IN_ _REF NB_ _IN_ _SET pVAL
GO:0016616 oxidoreductase activity, acting on the CH-OH group of 160 3 0.001262
donors, NAD or NADP as acceptor
GO:0016919 nardilysin activity 1 1 0.001353
GO:0050576 3-keto-steroid reductase activity 1 1 0.001353
GO:0004506 squalene monooxygenase activity 1 1 0.001353
GO:0048408 epidermal growth factor binding 1 1 0.001353
GO:0047747 cholate-CoA ligase activity 1 1 0.001353
GO:0016614 oxidoreductase activity, acting on CH-OH group of donors 174 3 0.001597
GO:0004161 dimethylallyltranstransferase activity 2 1 0.002702
GO:0004337 geranyltranstransferase activity 2 1 0.002702
GO:0000247 C-8 sterol isomerase activity 2 1 0.002702
GO:0016491 oxidoreductase activity 1510 7 0.002977
GO:0004769 steroid delta-isomerase activity 3 1 0.004048
GO:0017147 Wnt-protein binding 3 1 0.004048
GO:0004505 phenylalanine 4-monooxygenase activity 3 1 0.004048
GO:0004090 carbonyl reductase (NADPH) activity 3 1 0.004048
GO_ _ID TERM NB_ _IN_ _REF NB_ _IN_ _SET pVAL
GO:0004146 dihydrofolate reductase activity 3 1 0.004048
GO:0004450 isocitrate dehydrogenase (NADP+) activity 4 1 0.00539
GO:0003847 1-alkyl-2-acetylglycerophosphocholine esterase activity 6 1 0.008064
GO:0016874 ligase activity 630 4 0.008635
GO:0042043 neurexin binding 7 1 0.009396
doi:10.1371/journal.pone.0009063.t002
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lation in HepG2 cells on treatment with TNFa (0.5 nM) for 12 h
(Figure 7A). In an attempt to understand which of the above
TNFa-altered genes of this pathway is the most significant
contributor for the observed increase in the cholesterol levels in
the presence of TNFa, siRNAs were used to knock down the
specific genes namely SQLE, FDPS and EBP. Use of the siRNAs
could knock down the levels of the respective proteins by 75%
(data not shown). Figure 7B shows the effect of TNFa on the
cellular cholesterol levels in the presence of the siRNAs. In cells
transfected with SQLE or FDPS siRNAs, the TNFa-mediated
increase in the cellular cholesterol content was significantly
(p,0.01) prevented with SQLE siRNA demonstrating a higher
fold of prevention. EBP siRNA however depicted a very mild
preventive effect. All these indicate that of these three enzymes of
the steroid biosynthetic pathway that are up-regulated by TNFa,
SQLE is the most significant contributor of the elevated synthesis
of cholesterol by TNFa in HepG2 cells. This pathway emerging as
the top canonical pathway is therefore indicative of a correlation
between cellular lipid homeostasis and the inflammatory molecule
that may possibly underlie the pathogenesis of several diseases.
Discussion
TNFa is a major proinflammatory cytokine that activates varied
cellular signaling pathways resulting in diverse biological respons-
es. Within the liver, TNFa is known to regulate contrasting
processes. On the one hand, during liver regeneration for e.g.after
partial hepatectomy TNFa induces hepatocyte proliferation
thereby regulating normal cell function while on the other hand,
in the presence of any hepatocyte injury, TNFa production can
also trigger cell death rather than proliferation. TNFa therefore is
a crucial deciding factor between hepatocyte life and death and
therefore of global liver homeostasis. In the context of these
paradoxically contrasting hepatic responses towards TNFa,w e
employed high density oligonucleotide arrays (Human Genome
U133 plus 2.0, Affymetrix) to identify hepatic genes altered by
TNFa and elucidate the common transcriptional regulatory
controls among the altered genes.
Microarray analysis of HepG2 genes altered by TNFa identified
67 genes to be up- and 73 genes to be down-regulated. Very
significantly and consistently altered were genes of lipid metabo-
lism mainly squalene epoxidase, fatty acid desaturase, farnesyl
diphosphate synthase and hydroxysteroid (17-b) dehydrogenase 7
thus indicating lipid metabolism to be crucially targeted by TNFa.
This suitably agrees with the fact that TNFa is very significant in
the pathogenesis of fatty liver diseases that accompanies a host of
metabolic disorders. TNFa has been shown to induce fat
accumulation in the liver resulting in hepatic steatosis [40]. In
fact, Ruan et al., [41] also reported that squalene epoxidase and
farnesyl diphosphate synthase were increased by 2.4 and 1.7 fold
respectively in the rat liver on infusion with TNFa. The
transcription factor, CEBPa is implicated in the regulation of
numerous liver-specific genes and it is a critical regulator of
hepatic metabolism [42–46] and our results are in agreement with
earlier reports [47,48] that show a significant inhibition of CEBPa
by TNFa thereby implying a major alteration of cellular
metabolism.
The transcription factor, ATF5 binds to the cAMP response
element (CRE) on cAMP inducible promoters and regulates
Table 3. Over representation of conserved transcription
factor binding sites within putatively co-regulated genes.
GO term and Gene Symbol* Transcription Factors Probability**
Metabolism
SQLE, EBP, TIMP1, DHRS4, UBE2J1, FOXJ2 3.31E-156
UBE2NL, PAH, HSP90B1, GCDH FOXD3 5.75E-136
DHFR, FADS, SIRT6, AKR1B1 HFH-3 2.42E-128
C4B, SLC25A5 IRF-1 4.06E-108
SREBP-1 1.41E-53
E47 1.17E-52
MEF-2 6.67E-42
AREB6 9.87E-41
ARP-1 1.51E-35
Signal Transduction
TBL1X, RYK, DDX54, TNFRSF14, FOXJ2 3.04E-58
KISSIR, FCER1G, NFkB2 FOXD3 5.50E-58
IRF-1 3.42E-52
HFH-3 8.90E-48
SREBP-1 2.71E-19
CHOP:C/EBPalpha 2.51E-14
ARP-1 1.26E-13
Freac-7 2.98E-12
E47 2.78E-11
MEF-2 5.14E-11
Regulation of biological
processess
CASZ1, PUM1, C4B, GTF2H3 MEF-2 1.06E-14
ATF5, CHOP:C/EBPalpha 1.93E-14
FOXJ2 6.57E-13
AREB6 3.25E-12
SREBP-1 3.96E-12
ARP-1 1.69E-11
p300 2.32E-11
FOXD3 3.39E-11
SREBP-1 3.09E-10
NF-E2 3.89E-10
*Genes that clustered together and occurred within the same GO term.
**Significant probability of the binding of the respective transcription factors to
the indicated sets of genes.
doi:10.1371/journal.pone.0009063.t003
Table 4. Sequences for the binding elements and their
mutated counterparts used in the EMSA analysis.
SREBP-1 FP 59 GATCCTGATCACCCCACTGAGGAG 39
SREBP-1 RP 59 CTCCTCAGTGGGGTGATCAGGATC 39
SREBP-1 mutated FP 59 GATCCTGATCTCCCGACTGAGGAG 39
SREBP-1 mutated RP 59 CTCCTCAGTCGGGAGATCAGGATC 39
FOXJ2 FP 59 CACATAAACAAATACATCA39
FOXJ2 RP 59 TGATGTATTTGTTTATGTG 39
FOXJ2 mutated FP 59 CACGTAAGCAAATACATCA 39
FOXJ2 mutated RP 59 TGATGTATTTGCTTACGTG 39
FP: Forward Primer.
RP: Reverse Primer.
Poistions of alterations in the mutated oligonucleotides within the binding
motifs are shown by bold and underlined bases.
doi:10.1371/journal.pone.0009063.t004
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hepatic carcinomas [50]. Not reported earlier, our demonstration
of ATF5 being regulated by TNFa in HepG2 cells, therefore, is
indicative of its participation in the cellular role of TNFa in
hepatic physiology. Our results also demonstrated that genes
involved in cell death and cell proliferation were significantly
altered by TNFa. Earlier reports also demonstrated the same with
the transcription factor NF-kB and c-jun playing a significant
mediatory role therein [51,52]. TNFa acts primarily through the
NFkB and MAPK pathways and their activation is observed
immediately as initiators of downstream signaling cascades. In our
study, we observed activation of two downstream molecules of
these pathways namely, NFKB2 (Nuclear Factor of Kappa light
Polypeptide Gene Enhancer in B-cells 2) and MKNK2 (MAPK
interacting serine/threonine kinase 2). NFKB2 is a subunit of
NFkB that has been shown to be increased at the mRNA and
protein level by TNFa [53] and its inappropriate activation is
linked to varied pathophysiological states. MKNK2 contains a
MAPK binding and activating motif and it participates in the
regulation of protein biosynthesis and translation, in the protein
kinase cascade and in response to stress. The involvement of the
MAPK pathway in TNFa-induced toxic liver injury was reported
in an in vivo mouse model [54] and our study has demonstrated
an up-regulation of MKNK2 by 1.8-fold in HepG2 cells by TNFa.
Also, MKNK2 is known to interact with TRAF2 (TNF receptor-
associated factor 2) and thereby play a significant role in TNFa
receptor activity associated cellular phenomena.
Genes involved in ‘‘Cell Adhesion’’ were significantly down
regulated implying a compromise in these phenomena by TNFa
within the hepatocyte. In our study we found laminin gamma 1
(LAMC1) and TIMP 1 to be significantly down regulated (21.4
fold and 21.5 fold respectively) by TNFa indicating a modulation
of the extracellular matrix. The regulation of laminin, TIMP1 and
MMP9 by TNFa has been described [55–59] and here our results
show decreased expression of TIMP1 that together with the
decreased laminin gamma 1 expression indicate towards a
modulation of the extracellular matrix and thereby of cell adhesion
within the hepatocyte by TNFa.
Interestingly, in the present study, a catalog of genes not earlier
reported to be regulated by TNFa were found to be altered in
HepG2 cells. Significant among these were those from the GO
term: nucleic acid metabolism mainly DHFR, MTHFS, SIRT6
and DNMT3B; almost all of these are involved in the synthesis,
degradation or function of nucleic acids. Nucleic acids and their
metabolites are critical in the elucidation of an immune response
[60] and the alteration of these genes by TNFa as identified in our
study could at least in part possibly explain the role of nucleic acids
in the effects of TNFa in HepG2 cells. Also several altered genes
Figure 4. Electrophoretic mobility shift assay in control and TNFa-treated nuclear extracts using SREBP-1 and FOXJ2
oligonucleotide probes. 15 mg of nuclear extracts from control or TNFa-treated cells were incubated with labeled probes harboring the binding
elements of either SREBP-1 (A) or FOXJ2 (C). On termination of incubation they were resolved in a non-denaturing polyarylamide gel and subjected to
phosphorimager analysis. Mutated oligonucleotides with altered binding motifs of these two transcription factors were used to check the specificity
of the DNA-protein complexes. All experiments were done in triplicate. B and D: Densitometric analyses of the binding of SREBP-1 (B) and FOXJ2 (D)
respectively. Each point is the mean6SEM of three independent experiments. Lane 1: Labeled probe alone; Lane 2: Labeled probe incubated with
nuclear extract from control cells; Lane 3: Labeled probe incubated with nuclear extract from TNFa-treated cells; Lane 4: Labeled mutated probe
incubated with the nuclear extract from control cells. *p,0.05 as compared to Lane 1; **p,0.01 as compared to Lanes 1 and 2; ***p,0.001 as
compared to Lanes 1 and 2.
doi:10.1371/journal.pone.0009063.g004
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RASSF7, RGL3, KISSIR and RYK are being reported here for
the first time to be regulated by TNFa. RASSF7 and RGL3 are
significant signaling intermediates of the RAS pathway and their
alterations indicate towards modulation of this important cellular
signaling cascade by TNFa in HepG2 cells. Another important
molecule affected by TNFa is the gene RYK receptor like tyrosine
kinase (RYK) that like RTKs are deregulated in cancers [61] and
our revelation of the regulation of its gene expression by TNFa in
HepG2 cells could provide information surrounding these
phenomena. Our study, therefore, apart from demonstrating the
effects of TNFa on genes already known to be regulated as such,
has also unearthed several genes that were hitherto not known to
be regulated by TNFa.
Several well characterized and other not so well characterized
transcription factors were identified with binding elements in sets
of co-regulated genes. Myocyte enhancer factor 2 or MEF-2 family
of transcription factors that bind as homo- and heterodimers to the
MEF2 sites in the promoter regions of target genes were found to
be the most enriched in genes that belonged to the ‘‘Regulation of
Biological Processes’’ GO term (Table 3) suggesting that this may
be a major determiner of these processes within the hepatocyte.
Sterol Regulatory Element Binding Proteins (SREBPs) are a basic-
helix-loop-helix leucine zipper class of transcription factors that
bind to the sterol regulatory element DNA sequence TCACNC-
CAC. Within the liver, this transcription factor is known to
regulate several hepatic processes mainly gluconeogenesis [62],
lipid and cholesterol biosynthesis [63] and thereby attains
significance in diverse metabolic disturbances. TNFa has been
shown to stimulate the maturation of SREBP-1 in hepatocytes [64]
and our results demonstrated herein imply that SREBP-1 could be
important in mediating the effects of TNFa on these genes.
Interferon regulatory factor 1 or IRF-1 is a member of the
interferon regulatory transcription factor (IRF) family and
activates interferon transcription as well as of genes induced by
interferons [65]. IRF1 exhibits regulatory roles in diverse cellular
processess [66,67] and it has been associated with some forms of
cancer mainly lung and gastric cancer. Our demonstration of IRF-
1 depicting a high probability of over-representation in genes that
belonged to the ‘‘Metabolism’’ and ‘‘Signal Transduction’’ GO
termsindicates that this factor might modulate genes involved with
these GO terms and thereby underlie the crosstalk between
inflammation and cell cycle phenomena on the one end and
general cellular metabolism on the other.
Figure 5. Interacting network among genes altered by TNFa in HepG2 cells. Functional interacting network among genes altered with a
log2 ratio of 60.5 in HepG2 cells by TNFa. All such genes were uploaded in the Ingenuity Pathway Analysis tool and the network of ‘‘lipid metabolism,
small molecule biochemistry, nervous system development and function’’ that was identified with a significant score is depicted. Genes from our
dataset and falling in this network are shown in either red (up-regulated) or green (down regulated) with the intensity of the color being an indicator
of the fold change.
doi:10.1371/journal.pone.0009063.g005
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PLoS ONE | www.plosone.org 11 February 2010 | Volume 5 | Issue 2 | e9063Figure 6. ‘‘Biosynthesis of steroids’’ identified as the top canonical pathway altered by TNFa in HepG2 cells. Significant positions of the
pathway are occupied by genes from our dataset indicating that this pathway is invariably affected by TNFa in HepG2 cells. These positions have
been marked with solid diamond boxes in the figure. All the genes clustered at this part of the complete ‘‘Biosynthesis of steroids’’ pathway and
therefore are indicative of the role of TNFa in the regulation of this pathway within the hepatocyte. 1.14.99.7: Squalene Epoxidase; 5.3.3.5: Emopamil
Binding Protein (sterol isomerase); 2.5.1.1, 2.5.1.10, 2.5.1.129: forms of Farnesyl Diphosphate Synthase.
doi:10.1371/journal.pone.0009063.g006
Gene Profiling by TNFa
PLoS ONE | www.plosone.org 12 February 2010 | Volume 5 | Issue 2 | e9063Other than these, the less well characterized but emerging to be
possessing significant binding elements in our dataset include
FOXD3, FOXJ2 and HFH-3. These belong to the forkhead box
proteins (FOX proteins) that were initially known as regulators of
embryonic development and have now been recognized to play
important roles in regulating the expression of genes involved in
cell growth, proliferation and differentiation. FOXD3 has recently
been shown to be involved in the maintenance of neural crest and
pluripotent cells [68,69]. The expression of FOXJ2 starts early in
life and continues till adulthood. It binds to two different DNA
binding sites [70] and our depiction of its enhanced binding to its
element in the presence of TNFa suggests that it might be critical
in the TNFa action in HepG2 cells. The hepatocyte nuclear
factor-3 (HNF-3) fork head homolog (HFH) proteins share
homology to the winged helix DNA binding domain and have
been implicated in cell development and organogenesis [71].
Study of the role of these factors in the context of various cellular
processes, alterations of which, underlie the pathogenesis of several
diseases is an area worthy of investigation.
One of the most significant networks that emerged from the
TNFa induced altered genes was that of lipid metabolism and this
subsequently correlated well with the top canonical pathway, the
biosynthesis of steroids. TNFa increases hepatic cholesterol
synthesis [72] and interferes with lipid homeostasis [73].
Modulation of SQLE and FDPS has been shown to alter
intracellular hepatic cholesterol synthesis [74–76] implying their
significance in this pathway. Also, SREBP-1 has been demon-
strated to regulate the expression of these genes in HepG2 cells
and the liver [77,78] that also additionally validates our
transcription factor predictions and analyses. In our study, TNFa
significantly elevated intracellular cholesterol levels in HepG2 cells
which validates our claim of this pathway being the most favored
and in these series of events, SQLE is the most significant mediator
of the effects of TNFa on cholesterol synthesis. TNFa induces
hepatic steatosis in mice [40] with increased hepatic lipid synthesis
[72,79]. Such an effect of TNFa on hepatic lipid homeostasis was
also reported recently by Qin et al. [80] where they demonstrated
that in vivo infusion of TNFa significantly increased hepatic
production of total circulatory apolipoprotein B100 and VLDL
apolipoprotein B100 in fasting and post prandial states in a
hamster model.
To conclude, our results demonstrate that TNFa induced
alteration in the hepatocyte transcriptome majorly includes genes
of lipid metabolism that acutely targets biosynthesis of steroids and
cholesterol. While several characterized transcription factors were
consistently found to be having binding elements in these sets of
genes, others mainly those of the fork head family that are not too
well characterized also appeared to be substantially over
represented. Our results presented here put forth an overall
detailed analysis of the action of TNFa in HepG2 cells by
encompassing the altered gene expression profile, the different GO
functional terms these altered genes categorise in and the
consequent predicted signatures of conserved transcription factor
binding sites in these sets of genes. Given that TNFa is now
invariably being associated with several diseases, our results
provide information towards identification of the underlying genes
and transcription factors that determine among other significant
liver phenotypes, hepatic steatosis and fatty liver that are critically
associated with several pathological states.
Supporting Information
Figure S1 Dose and time dependent effect of TNFa on insulin
stimulated Akt phosphorylation in HepG2 cells.
Found at: doi:10.1371/journal.pone.0009063.s001 (0.11 MB TIF)
Figure S2 Hierarchical cluster of the differentially expressed
genes.
Found at: doi:10.1371/journal.pone.0009063.s002 (0.31 MB TIF)
Table S1 Genes altered by TNFa treatment in HepG2 cells.
Found at: doi:10.1371/journal.pone.0009063.s003 (0.19 MB
DOC)
Table S2 Gene Ontology (Biological Processes) terms overrep-
resented (p,0.01) in the set of genes altered by TNFa.
Found at: doi:10.1371/journal.pone.0009063.s004 (0.23 MB
DOC)
Figure 7. Effect of TNFa on cholesterol synthesis in HepG2
cells. A.HepG2 cells were incubated in the absence (C) or presence
of TNFa (0.5 nM, 12 h) and cells were lysed and lipids were extracted
by addition of 1.0 ml of chloroform: methanol (2:1). B. HepG2 cells
were transfected with 50 nM of either control (Con siRNA) or SQLE
or FDPS or EBP siRNAs. After 48 h, they were incubated either alone
or in the presence of TNFa as in ‘‘A’’. Cholesterol was estimated in
the extracted lipid fraction as described in the Methods section.
Results are expressed after normalization to the total protein
content. Each value is the mean6 SEM of three experiments.
*p,0.05 as compared to control (C), determined using Student’s t
test (A). *p,0.001 as compared to ConsiRNA; **p,0.01 and
***p,0.05 as compared to the incubation of TNFa alone in the
presence of ConsiRNA (B).
doi:10.1371/journal.pone.0009063.g007
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